cro.directory
← Compare landing

Altasciences vs Premier Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/altasciences/premier-research

CategoryAltasciencesPremier Research
Listed sitebothcro
SummaryMid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
Services
  • Preclinical In Vivo Studies
  • GLP Toxicology
  • Safety Pharmacology
  • In Vitro Pharmacology
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Clinical Trial Services
  • Bioanalysis
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Medical Writing
  • Clinical Operations
  • Regulatory Affairs
  • In Vivo PK / PD Studies
  • Preclinical In Vitro Studies
  • Phase IV / Post-Marketing
  • In Vitro ADME / DMPK
  • Formulation Development
  • Stability Testing & Storage
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Clinical Trial Services
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Central Laboratory Services
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
  • GLP Toxicology
  • Safety Pharmacology
  • In Vitro ADME / DMPK
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Device & Combination Product Services
Modalities
  • Small Molecule
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Peptide
Indications
  • Cardiovascular
  • Dermatology
  • Gastroenterology
  • Immunology
  • Infectious Disease
  • Metabolic
  • Neurology
  • Oncology
  • Ophthalmology
  • Psychiatry
  • Respiratory
  • Women's Health
  • Oncology
  • Immunology
  • Neurology
  • Infectious Disease
  • Rare Disease
  • Dermatology
  • Women's Health
Locations
  • Headquarters, Montreal, Quebec, Canada
  • Bioanalytical Laboratory, Laval, Quebec, Canada
  • Clinical Site, Montreal, Quebec, Canada
  • Clinical and Research Campus, Overland Park, Kansas, United States
  • Preclinical Testing, Everett, Washington, United States
  • Manufacturing and Analytical Services, Harleysville, Pennsylvania, United States
  • Preclinical Testing, Scranton, Pennsylvania, United States
  • Preclinical Testing, Columbia, Missouri, United States
  • Clinical Pharmacology, Cypress, California, United States
  • Preclinical Testing, Sacramento, California, United States
  • Laval, Laval, Quebec, Canada
  • Overland Park, Overland Park, Kansas, United States
  • Everett, Everett, Washington, United States
  • Harleysville, Harleysville, Pennsylvania, United States
  • Cypress, Cypress, California, United States
  • Scott Township, Scott Township, Pennsylvania, United States
  • Auxvasse, Auxvasse, Missouri, United States
  • Sacramento, Sacramento, California, United States
  • Canada, Canada, Canada
  • United States, United States, United States
  • Canada and U.S. operations
  • Headquarters, Morrisville, NC, United States
  • Southbank, Southbank, VIC, Australia
  • Sofia, Sofia, Bulgaria
  • Toronto, Mississauga, ON, Canada
  • Prague, Praha, Czech Republic
  • Paris, Paris, France
  • Darmstadt, Darmstadt, Germany
  • Budapest, Budapest, Hungary
  • Bengaluru, Bengaluru, India
  • Auckland, Auckland, New Zealand
  • Warsaw, Warszawa, Poland
  • Bucharest, Bucharest, Romania
  • Bratislava, Bratislava, Slovakia
  • Seoul, Seoul, South Korea
  • Madrid, Madrid, Spain
  • Taipei, Taipei, Taiwan
  • Kyiv, Kyiv, Ukraine
  • Wokingham, Wokingham, Berkshire, United Kingdom
Certifications
  • FDA · Identifier: FDA inspection passed 2001
  • GLP · Identifier: GLP Compliant
  • GMP · Identifier: GMP Manufacturing
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.